Mercurio Giovanna, Giacco Antonia, Scopigno Nicla, Vigliotti Michela, Goglia Fernando, Cioffi Federica, Silvestri Elena
Department of Science and Technology, University of Sannio, Via De Sanctis, 82100 Benevento, Italy.
Nutrients. 2025 Mar 30;17(7):1214. doi: 10.3390/nu17071214.
Nonalcoholic fatty liver disease (NAFLD) is a growing global health concern that is closely linked to metabolic syndrome, yet no approved pharmacological treatment exists. The Mediterranean diet (MD) emerged as a first-line dietary intervention for NAFLD, offering metabolic and hepatoprotective benefits. Now conceptualized as a complex chemical matrix rich in bioactive compounds, the MD exerts antioxidant and anti-inflammatory effects, improving insulin sensitivity and lipid metabolism. Mitochondria play a central role in NAFLD pathophysiology, influencing energy metabolism, oxidative stress, and lipid homeostasis. Emerging evidence suggests that the MD's bioactive compounds enhance mitochondrial function by modulating oxidative phosphorylation, biogenesis, and mitophagy. However, most research has focused on individual compounds rather than the MD as a whole, leaving gaps in understanding its collective impact as a complex dietary pattern. This narrative review explores how the MD and its bioactive compounds influence mitochondrial health in NAFLD, highlighting key pathways such as mitochondrial substrate control, dynamics, and energy efficiency. A literature search was conducted to identify relevant studies on the MD, mitochondria, and NAFLD. While the search was promising, our understanding remains incomplete, particularly when current knowledge is limited by the lack of mechanistic and comprehensive studies on the MD's holistic impact. Future research integrating cutting-edge experimental approaches is needed to elucidate the intricate diet-mitochondria interactions. A deeper understanding of how the MD influences mitochondrial health in NAFLD is essential for developing precision-targeted nutritional strategies that can effectively prevent and manage the disease.
非酒精性脂肪性肝病(NAFLD)是一个日益引起全球健康关注的问题,它与代谢综合征密切相关,但目前尚无获批的药物治疗方法。地中海饮食(MD)已成为NAFLD的一线饮食干预措施,具有代谢和肝脏保护作用。现在,MD被概念化为一种富含生物活性化合物的复杂化学基质,具有抗氧化和抗炎作用,可改善胰岛素敏感性和脂质代谢。线粒体在NAFLD病理生理学中起核心作用,影响能量代谢、氧化应激和脂质稳态。新出现的证据表明,MD的生物活性化合物通过调节氧化磷酸化、生物发生和线粒体自噬来增强线粒体功能。然而,大多数研究都集中在个别化合物上,而不是整个MD,这使得在理解其作为一种复杂饮食模式的总体影响方面存在空白。这篇叙述性综述探讨了MD及其生物活性化合物如何影响NAFLD中的线粒体健康,重点介绍了线粒体底物控制、动力学和能量效率等关键途径。我们进行了文献检索,以确定关于MD、线粒体和NAFLD的相关研究。虽然检索结果很有希望,但我们的理解仍然不完整,特别是当当前的知识受到关于MD整体影响的机制和全面研究缺乏的限制时。需要整合前沿实验方法的未来研究来阐明复杂的饮食-线粒体相互作用。深入了解MD如何影响NAFLD中的线粒体健康对于制定能够有效预防和管理该疾病的精准营养策略至关重要。